Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, exits, promotions and layoffs occurring across the healthcare industry.
Here is a selection of recent executive hires, exits, promotions and layoffs occurring across the healthcare industry.
The diagnostics company currently has an authorized at-home Covid-19 test, and plans to expand into flu tests and other diagnostics. After pricing its stock at $16 per share, it climbed to $20 on Friday.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
The San Diego-based company began marketing its first product, a portable Covid-19 test, after receiving an emergency use authorization last year. Now, it’s filing the initial paperwork to go public as it scales up manufacturing.
Cue Health, a startup that won a big government contract for its at-home Covid-19 test, recently raised $235 million in funding. The startup plans to use the funds to grow and offer additional types of tests.
As the Biden Administration pushes to offer more over-the-counter Covid-19 tests, the Food and Drug Administration authorized the first molecular Covid-19 test for over-the-counter use. The test was developed by San Diego-based startup Cue Health.
San Diego-based diagnostics startup Cue Health won a $481 million from the Department of Health and Human Services and the Department of Defense to produce more coronavirus tests. The company received an emergency use authorization in June for its rapid molecular test.
Alpha Health, a startup looking to automate revenue cycle management, raised $20 million in funding from Andreesen Horowitz. Read more about startups that announced funding rounds this week.
Cue Health, a startup developing a connected testing device, closed a $100 million series C round. The company recently submitted its system to the FDA for emergency use authorization to be used for onsite Covid-19 testing.